Lipödemde Patofizyolojik Mekanizmalar-İnflamasyon ve Ekstraselüler Matriks Değişiklikleri

Al-Ghadban S, Guo Y, Juskiewicz ZJ, Crescenzi R, Li X, Isakson BE, et al. Vascular changes and their implications in lipedema. Front Cell Dev Biol. 2026;14:1819443.

Al-Ghadban S, Cromer W, Allen M, Ussery C, Badowski M, Harris D, et al. Dilated blood and lymphatic microvessels, angiogenesis, increased macrophages, and adipocyte hypertrophy in lipedema thigh skin and fat tissue. J Obes. 2019;2019:8747461. doi:10.1155/2019/8747461.

Poojari A, Dev K, Rabiee A. Lipedema: insights into morphology, pathophysiology, and challenges. Biomedicines. 2022;10:3081. doi:10.3390/biomedicines10123081.

Wolf S, Rannikko JH, Virtakoivu R, Cinelli P, Felmerer G, Burger A, et al. A distinct M2 macrophage infiltrate and transcriptomic profile decisively influence adipocyte differentiation in lipedema. Front Immunol. 2022;13:1004609. doi:10.3389/fimmu.2022.1004609.

Grewal T, Kempa S, Buechler C. Lipedema: a disease triggered by M2 polarized macrophages? Biomedicines. 2025;13:561. doi:10.3390/biomedicines13030561.

Kruppa P, Gohlke S, Łapiński K, Garcia-Carrizo F, Soultoukis GA, Infanger M, et al. Lipedema stage affects adipocyte hypertrophy, subcutaneous adipose tissue inflammation and interstitial fibrosis. Front Immunol. 2023;14:1223264. doi:10.3389/fimmu.2023.1223264.

Felmerer G, Stylianaki A, Hägerling R, Wang A, Ströbel P, Hollmén M, et al. Adipose tissue hypertrophy, an aberrant biochemical profile and distinct gene expression in lipedema. J Surg Res. 2020;253:294-303. doi:10.1016/j.jss.2020.03.055.

Thomas D, Apovian C. Macrophage functions in lean and obese adipose tissue. Metabolism. 2017;72:120-143. doi:10.1016/j.metabol.2017.04.005.

Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003;112(12):1796-1808. doi:10.1172/JCI200319246.

Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003;112(12):1821-1830. doi:10.1172/JCI200319451.

Chawla A, Nguyen KD, Goh YPS. Macrophage-mediated inflammation in metabolic disease. Nat Rev Immunol. 2011;11(11):738-749. doi:10.1038/nri3071.

Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest. 2007;117(1):175-184. doi:10.1172/JCI29881.

Maffeis C, Silvagni D, Bonadonna R, Grezzani A, Banzato C, Tato L. Fat cell size, insulin sensitivity, and inflammation in obese children. J Pediatr. 2007;151(6):647-652. doi:10.1016/j.jpeds.2007.04.053.

Acosta JR, Douagi I, Andersson DP, Backdahl J, Rydén M, Arner P, et al. Increased fat cell size: a major phenotype of subcutaneous white adipose tissue in nonobese individuals with type 2 diabetes. Diabetologia. 2016;59(3):560-570. doi:10.1007/s00125-015-3810-6.

Pietilainen KH, Kannisto K, Korsheninnikova E, Rissanen A, Kaprio J, Ehrenborg E, et al. Acquired obesity increases CD68 and tumor necrosis factor-alpha and decreases adiponectin gene expression in adipose tissue: a study in monozygotic twins. J Clin Endocrinol Metab. 2006;91(7):2776-2781. doi:10.1210/jc.2005-2848.

Skurk T, Alberti-Huber C, Herder C, Hauner H. Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab. 2007;92(3):1023-1033. doi:10.1210/jc.2006-1055.

Bahceci M, Gokalp D, Bahceci S, Tuzcu A, Atmaca S, Arikan S. The correlation between adiposity and adiponectin, tumor necrosis factor alpha, interleukin-6 and high sensitivity C-reactive protein levels. Is adipocyte size associated with inflammation in adults? J Endocrinol Invest. 2007;30(3):210-214. doi:10.1007/BF03347427.

Henninger AM, Eliasson B, Jenndahl LE, Hammarstedt A. Adipocyte hypertrophy, inflammation and fibrosis characterize subcutaneous adipose tissue of healthy, non-obese subjects predisposed to type 2 diabetes. PLoS One. 2014;9(8). doi:10.1371/journal.pone.0105262.

Morisset AS, Huot C, Légaré D, Tchernof A. Circulating IL-6 concentrations and abdominal adipocyte isoproterenol-stimulated lipolysis in women. Obesity (Silver Spring). 2008;16(7):1487-1492. doi:10.1038/oby.2008.242.

Pinnick KE, Nicholson G, Manolopoulos KN, McQuaid SE, Valet P, Frayn KN, et al. Distinct developmental profile of lower-body adipose tissue defines resistance against obesity-associated metabolic complications. Diabetes. 2014;63(11):3785-3797. doi:10.2337/db14-0385.

Felmerer G, Stylianaki A, Hollmén M, Ströbel P, Stepniewski A, Wang A, et al. Increased levels of VEGF-C and macrophage infiltration in lipedema patients without changes in lymphatic vascular morphology. Sci Rep. 2020;10:10947. doi:10.1038/s41598-020-67987-3.

Kruglikov IL, Scherer PE. Is the endotoxin-complement cascade the major driver in lipedema? Trends Endocrinol Metab. 2024;35:769-780. doi:10.1016/j.tem.2024.04.004.

Baluk P, Hogmalm A, Bry M, Alitalo K, Bry K, McDonald DM. Transgenic overexpression of interleukin-1β induces persistent lymphangiogenesis but not angiogenesis in mouse airways. Am J Pathol. 2013;182:1434-1447. doi:10.1016/j.ajpath.2012.12.003.

Cao R, Eriksson A, Kubo H, Alitalo K, Cao Y, Thyberg J. Comparative evaluation of FGF-2-, VEGF-A-, and VEGF-C-induced angiogenesis, lymphangiogenesis, vascular fenestrations, and permeability. Circ Res. 2004;94:664-670. doi:10.1161/01.RES.0000118600.91698.BB.

Tacconi C, Correale C, Gandelli A, Spinelli A, Dejana E, D'Alessio S, et al. Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion. Gastroenterology. 2015;148:1438-1451.e8. doi:10.1053/j.gastro.2015.03.005.

Breslin JW, Yuan SY, Wu MH. VEGF-C alters barrier function of cultured lymphatic endothelial cells through a VEGFR-3-dependent mechanism. Lymphat Res Biol. 2007;5:105-113. doi:10.1089/lrb.2007.1004.

Michelini S, Greco S, Vaia N, Puleo V, Pellegrino P, Di Vincenzo A, et al. Endothelial cell alterations in capillaries of adipose tissue from patients affected by lipedema. Obesity (Silver Spring). 2025;33:695-708. doi:10.1002/oby.24244.

Szolnoky G, Ifeoluwa A, Tuczai M, Varga E, Varga M, Dosa-Racz E, et al. Measurement of capillary fragility: a useful tool to differentiate lipedema from obesity? Lymphology. 2017;50:203-209.

Xiong S, Hong Z, Huang LS, Tsukasaki Y, Nepal S, Di A, et al. IL-1β suppression of VE-cadherin transcription underlies sepsis-induced inflammatory lung injury. J Clin Invest. 2020;130:3684-3698. doi:10.1172/JCI136908.

Hofmann S, Grasberger H, Jung P, Bidlingmaier M, Vlotides J, Janssen OE, et al. The tumour necrosis factor-α induced vascular permeability is associated with a reduction of VE-cadherin expression. Eur J Med Res. 2002;7:171-176.

Duhon BH, Phan TT, Taylor SL, Crescenzi RL, Rutkowski JM. Current mechanistic understandings of lymphedema and lipedema: tales of fluid, fat, and fibrosis. Int J Mol Sci. 2022;23:6621. doi:10.3390/ijms23126621.

Jiang X, Tian W, Kim D, McQuiston AS, Vinh R, Rockson SG, et al. Hypoxia and hypoxia-inducible factors in lymphedema. Front Pharmacol. 2022;13:851057. doi:10.3389/fphar.2022.851057.

Selak MA, Armour SM, MacKenzie ED, Boulahbel H, Watson DG, Mansfield KD, et al. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase. Cancer Cell. 2005;7:77-85. doi:10.1016/j.ccr.2004.11.022.

Wojtovich AP, Smith CO, Haynes CM, Nehrke KW, Brookes PS. Physiological consequences of complex II inhibition for aging, disease, and the mKATP channel. Biochim Biophys Acta. 2013;1827:598-611. doi:10.1016/j.bbabio.2012.12.007.

Tannahill GM, Curtis AM, Adamik J, Palsson-McDermott EM, McGettrick AF, Goel G, et al. Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature. 2013;496:238-242. doi:10.1038/nature11986.

Palsson-McDermott EM, O'Neill LAJ. Gang of 3: how the Krebs cycle-linked metabolites itaconate, succinate, and fumarate regulate macrophages and inflammation. Cell Metab. 2025;37:1049-1059. doi:10.1016/j.cmet.2025.03.004.

Mills E, O'Neill LA. Succinate: a metabolic signal in inflammation. Trends Cell Biol. 2014;24:317-320. doi:10.1016/j.tcb.2013.11.008.

Littlewood-Evans A, Sarret S, Apfel V, Loesle P, Dawson J, Zhang J, et al. GPR91 senses extracellular succinate released from inflammatory macrophages and exacerbates rheumatoid arthritis. J Exp Med. 2016;213:1655-1662. doi:10.1084/jem.20160061.

Guo Y, Xu F, Thomas SC, Zhang Y, Paul B, Sakilam S, et al. Targeting the succinate receptor effectively inhibits periodontitis. Cell Rep. 2022;40:111389. doi:10.1016/j.celrep.2022.111389.

Guo Y, Xie C, Li X, Yang J, Yu T, Zhang R, et al. Succinate and its G-protein-coupled receptor stimulates osteoclastogenesis. Nat Commun. 2017;8:15621. doi:10.1038/ncomms15621.

van Diepen JA, Robben JH, Hooiveld GJ, Carmone C, Alsady M, Boutens L, et al. SUCNR1-mediated chemotaxis of macrophages aggravates obesity-induced inflammation and diabetes. Diabetologia. 2017;60:1304–1313. doi:10.1007/s00125-017-4261-z.

Pu M, Zhang J, Hong F, Wang Y, Zhang C, Zeng Y, et al. The pathogenic role of succinate-SUCNR1: a critical function that induces renal fibrosis via M2 macrophage. Cell Commun Signal. 2024;22:78. doi:10.1186/s12964-024-01481-5.

Trauelsen M, Hiron TK, Lin D, Petersen JE, Breton B, Husted AS. Extracellular succinate hyperpolarizes M2 macrophages through SUCNR1/GPR91-mediated Gq signaling. Cell Rep. 2021;35:109246. doi:10.1016/j.celrep.2021.109246.

Ran S, Montgomery KE. Macrophage-mediated lymphangiogenesis: the emerging role of macrophages as lymphatic endothelial progenitors. Cancers (Basel). 2012;4:618–657. doi:10.3390/cancers4030618.

Sapieha P, Sirinyan M, Hamel D, Zaniolo K, Joyal JS, Cho JH, et al. The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis. Nat Med. 2008;14:1067–1076. doi:10.1038/nm.1873.

Atallah R, Gindlhuber J, Platzer W, Bärnthaler T, Tatzl E, Toller W, et al. SUCNR1 is expressed in human placenta and mediates angiogenesis: significance in gestational diabetes. Int J Mol Sci. 2021;22:12048. doi:10.3390/ijms222112048.

Toma I, Kang JJ, Sipos A, Vargas S, Bansal E, Hanner F, et al. Succinate receptor GPR91 provides a direct link between high glucose levels and renin release in murine and rabbit kidney. J Clin Invest. 2008;118:2526–2534. doi:10.1172/JCI33293.

Atallah R, Gindlhuber J, Platzer W, Rajesh R, Heinemann A. Succinate regulates endothelial mitochondrial function and barrier integrity. Antioxidants (Basel). 2024;13:1579. doi:10.3390/antiox13121579.

Rubic T, Lametschwandtner G, Jost S, Hinteregger S, Kund J, Carballido-Perrig N, et al. Triggering the succinate receptor GPR91 on dendritic cells enhances immunity. Nat Immunol. 2008;9:1261–1269. doi:10.1038/ni.1657.

Saraiva AL, Veras FP, Peres RS, Talbot J, de Lima KA, Luiz JP, et al. Succinate receptor deficiency attenuates arthritis by reducing dendritic cell traffic and expansion of Th17 cells in the lymph nodes. FASEB J. 2018;32:fj201800285. doi:10.1096/fj.201800285.

La Torre YSD, Wadeea R, Rosas V, Herbst KL. Lipedema: friend and foe. Horm Mol Biol Clin Investig. 2018;33:1.

Allen M, Schwartz M, Herbst KL. Interstitial fluid in lipedema and control skin. Womens Health Rep. 2020;1:480–487.

Ibarra M, Eekema A, Ussery C, Neuhardt D, Garby K, Herbst KL. Subcutaneous adipose tissue therapy reduces fat by dual X-ray absorptiometry scan and improves tissue structure by ultrasound in women with lipoedema and Dercum disease. Clin Obes. 2018;8:398–406.

Herbst KL, Kahn LA, Iker E, Ehrlich C, Wright T, McHutchison L, et al. Standard of care for lipedema in the United States. Phlebology. 2021;36:779–796.

Roberts MA, Mendez U, Gilbert RJ, Keim AP, Goldman J. Increased hyaluronan expression at distinct time points in acute lymphedema. Lymphat Res Biol. 2012;10:122–128.

Pessentheiner AR, Ducasa GM, Gordts PLSM, Reijmers RM, Apice LD, Pessentheiner AR, et al. Proteoglycans in obesity-associated metabolic dysfunction and meta-inflammation. Front Immunol. 2020;11:769.

evick JR, Michel CC. Microvascular fluid exchange and the revised Starling principle. Cardiovasc Res. 2010;87:198–210.

Tarbell JM, Simon SI, Curry FRE. Mechanosensing at the vascular interface. Annu Rev Biomed Eng. 2014;16:505–532.

Crescenzi R, Marton A, Donahue PMC, Mahany HB, Lants SK, Wang P, et al. Tissue sodium content is elevated in the skin and subcutaneous adipose tissue in women with lipedema. Obesity (Silver Spring). 2018;26:310–317.

Schierke F, Wyrwoll MJ, Wisdorf M, Niedzielski L, Maase M, Ruck T, et al. Nanomechanics of the endothelial glycocalyx contribute to Na+-induced vascular inflammation. Sci Rep. 2017;7:46476.

Al-Ghadban S, Pursell IA, Diaz ZT, Herbst KL, Bunnell BA. 3D spheroids derived from human lipedema ASCs demonstrated similar adipogenic differentiation potential and ECM remodeling to non-lipedema ASCs in vitro. Int J Mol Sci. 2020;21:8350.

Huber J, Löffler M, Bilban M, Reimers M, Kadl A, Todoric J, et al. Prevention of high-fat diet-induced adipose tissue remodeling in obese diabetic mice by n-3 polyunsaturated fatty acids. Int J Obes (Lond). 2007;31:1004–1013.

Goddi A, Carmona A, Schroedl L, White JM, Piron MJ, De Leon A, et al. Laminin-A4 is upregulated in both human and murine models of obesity. Front Endocrinol (Lausanne). 2021;12:886.

Pasarica M, Gowronska-Kozak B, Burk D, Remedios I, Hymel D, Gimble J, et al. Adipose tissue collagen VI in obesity. J Clin Endocrinol Metab. 2009;94:5155–5162.

Wang Y, Fu Y, Yan Z, Zhang XB, Pei M. Impact of fibronectin knockout on proliferation and differentiation of human infrapatellar fat pad-derived stem cells. Front Bioeng Biotechnol. 2019;7:321.

Mao Y, Schwarzbauer JE. Fibronectin fibrillogenesis, a cell-mediated matrix assembly process. Matrix Biol. 2005;24:389–399.

Arcidiacono B, Chiefari E, Laria AE, Messineo S, Bilotta FL, Britti D, et al. Expression of matrix metalloproteinase-11 is increased under conditions of insulin resistance. World J Diabetes. 2017;8:422–428.

Gesta S, Guntur K, Majumdar ID, Akella S, Vishnudas VK, Sarangarajan R, et al. Reduced expression of collagen VI alpha 3 (COL6A3) confers resistance to inflammation-induced MCP1 expression in adipocytes. Obesity (Silver Spring). 2016;24:1695–1703.

Kim HN, Chung HS. Caveolin-1 inhibits membrane-type 1 matrix metalloproteinase activity. BMB Rep. 2008;41:858–862.

Kruglikov IL, Joffin N, Scherer PE. The MMP14–caveolin axis and its potential relevance for lipoedema. Nat Rev Endocrinol. 2020;16:669–674.

Strohmeier K, Hofmann M, Jacak J, Narzt MS, Wahlmueller M, Mairhofer M, et al. Multi-level analysis of adipose tissue reveals the relevance of perivascular subpopulations and an increased endothelial permeability in early-stage lipedema. Biomedicines. 2022;10:1163.

Priglinger E, Strohmeier K, Weigl M, Lindner C, Auer D, Gimona M, et al. SVF-derived extracellular vesicles carry characteristic miRNAs in lipedema. Sci Rep. 2020;10:7211.

Pan Z, Zhou Z, Zhang H, Zhao H, Song P, Wang D, et al. CD90 serves as differential modulator of subcutaneous and visceral adipose-derived stem cells by regulating AKT activation that influences adipose tissue and metabolic homeostasis. Stem Cell Res Ther. 2019;10:355.

Wu Z, Liu J, Chen G, Du J, Cai H, Chen X, et al. CD146 is a novel ANGPTL2 receptor that promotes obesity by manipulating lipid metabolism and energy expenditure. Adv Sci (Weinh). 2021;8:2004032.

Navarro R, Compte M, Álvarez-Vallina L, Sanz L. Immune regulation by pericytes: modulating innate and adaptive immunity. Front Immunol. 2016;7:480.

Ahmed TA, Shousha WG, Abdo SM, Mohamed IK, El-Badri N. Human adipose-derived pericytes: biological characterization and reprogramming into induced pluripotent stem cells. Cell Physiol Biochem. 2020;54:271–286.

Rajasekaran M, Sul OJ, Choi EK, Kim JE, Suh JH, Choi HS. MCP-1 deficiency enhances browning of adipose tissue via increased M2 polarization. J Endocrinol. 2019;242:91–101.

Zhang Y, Mei H, Chang X, Chen F, Zhu Y, Han X. Adipocyte-derived microvesicles from obese mice induce M1 macrophage phenotype through secreted miR-155. J Mol Cell Biol. 2016;8:505–517.

Hou J, Shi J, Chen L, Lv Z, Chen X, Cao H, et al. M2 macrophages promote myofibroblast differentiation of LR-MSCs and are associated with pulmonary fibrogenesis. Cell Commun Signal. 2018;16:89.

Bauer AT, von Lukowicz D, Lossagk K, Hopfner U, Kirsch M, Moog P, et al. Adipose stem cells from lipedema and control adipose tissue respond differently to adipogenic stimulation in vitro. Plast Reconstr Surg. 2019;144:623–632.

Freund A, Chauveau C, Brouillet JP, Lucas A, Lacroix M, Licznar A, et al. IL-8 expression and its possible relationship with estrogen receptor-negative status of breast cancer cells. Oncogene. 2003;22:256–265.

Lin Y, Huang RP, Chen L, Li S, Shi Q, Jordan C, et al. Identification of interleukin-8 as an estrogen receptor-regulated factor involved in breast cancer invasion and angiogenesis by protein arrays. Int J Cancer. 2004;109:507–515